Fennec Pharmaceuticals (FENC) Share-based Compensation Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 338.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 338.07% |
| Sep 30, 2025 | 302.62% |
| Jun 30, 2025 | 249.48% |
| Mar 31, 2025 | 186.31% |
| Dec 31, 2024 | -33.02% |
| Sep 30, 2024 | 25.69% |
| Jun 30, 2024 | -11.31% |
| Mar 31, 2024 | 26.60% |
| Dec 31, 2023 | 244.29% |
| Sep 30, 2023 | -11.26% |
| Jun 30, 2023 | 394.74% |
| Mar 31, 2023 | 40.70% |
| Dec 31, 2022 | 29.14% |
| Sep 30, 2022 | 17.42% |
| Jun 30, 2022 | -52.71% |
| Mar 31, 2022 | -46.42% |
| Dec 31, 2021 | 33.22% |
| Sep 30, 2021 | 171.15% |
| Jun 30, 2021 | 151.86% |
| Mar 31, 2021 | 49.98% |
| Dec 31, 2020 | -72.08% |
| Sep 30, 2020 | 10.93% |
| Jun 30, 2020 | -58.13% |
| Mar 31, 2020 | 91.13% |
| Dec 31, 2019 | -44.97% |
| Sep 30, 2019 | -9.14% |
| Jun 30, 2019 | 169.03% |
| Dec 31, 2018 | 161.96% |
| Mar 31, 2018 | 168.39% |
| Dec 31, 2017 | 74.06% |
| Sep 30, 2017 | 95.17% |
| Mar 31, 2017 | -24.28% |
| Dec 31, 2016 | -22.28% |
| Sep 30, 2016 | -11.94% |
| Jun 30, 2016 | -16.31% |
| Dec 31, 2015 | -13.51% |
| Sep 30, 2014 | -1.84% |
| Sep 30, 2013 | -52.64% |
| Jun 30, 2013 | -75.83% |